Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Trip.com Group
TCOM
$29.6B
| $20.3M | 0.01% |
+431,210
| New | +$22M |
|
327
Enbridge
ENB
$119B
| $20.1M | 0.01% |
565,457
-11,963
| -2% | -$427K |
|
328
Kinetik
KNTK
$3.72B
| $19.9M | 0.01% |
479,061
+91,599
| +24% | +$3.64M |
|
329
Fortrea Holdings
FTRE
$1.82B
| $19.5M | 0.01% |
833,790
+670,354
| +410% | +$20.8M |
|
330
Hilltop Holdings
HTH
$2.26B
| $19.3M | 0.01% |
617,200
-246,395
| -29% | -$7.49M |
|
331
Enterprise Financial Services Corp
EFSC
$2.4B
| $18.9M | 0.01% |
462,038
+2,877
| +0.6% | +$112K |
|
|
ENLC
332
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $18.6M | 0.01% |
1,355,126
-32,789
| -2% | -$438K |
|
333
Heritage Financial
HFWA
$1.22B
| $18.3M | 0.01% |
1,015,801
+262,231
| +35% | +$4.71M |
|
334
LPL Financial
LPLA
$28.3B
| $18.1M | 0.01% |
+64,955
| New | +$17.6M |
|
335
NewAmsterdam Pharma
NAMS
$3.25B
| $18M | 0.01% |
937,163
+6,312
| +0.7% | +$127K |
|
336
Pinduoduo
PDD
$126B
| $17.9M | 0.01% |
134,596
-23,496
| -15% | -$3.18M |
|
|
GDEN
337
DELISTED
Golden Entertainment
GDEN
| $17.3M | 0.01% |
557,098
+12,084
| +2% | +$384K |
|
|
AAMI
338
Acadian Asset Management
AAMI
$3.08B
| $17.1M | 0.01% |
773,519
+14,128
| +2% | +$319K |
|
339
Canadian National Railway
CNI
$76.9B
| $17.1M | 0.01% |
145,093
+3,150
| +2% | +$394K |
|
|
EMBJ
340
Embraer S.A. ADS
EMBJ
$12.2B
| $17M | 0.01% |
658,987
+290,450
| +79% | +$7.86M |
|
341
Regal Rexnord
RRX
$13.7B
| $16.9M | 0.01% |
125,313
+1,285
| +1% | +$200K |
|
342
Houlihan Lokey
HLI
$8.77B
| $16.9M | 0.01% |
125,554
-221,611
| -64% | -$29M |
|
343
NeoGenomics
NEO
$1.96B
| $16.9M | 0.01% |
1,219,427
+167,800
| +16% | +$2.38M |
|
|
EXE
344
Expand Energy Corp
EXE
$21.8B
| $16.4M | 0.01% |
199,715
-368
| -0.2% | -$32.5K |
|
|
VRNA
345
DELISTED
Verona Pharma
VRNA
| $16.3M | 0.01% |
1,128,032
-465,801
| -29% | -$6.8M |
|
346
First Bancorp
FBNC
$2.6B
| $16M | 0.01% |
502,688
-538,644
| -52% | -$17.1M |
|
347
Vera Therapeutics
VERA
$2.3B
| $16M | 0.01% |
441,162
+366,223
| +489% | +$14.5M |
|
348
Hess Midstream
HESM
$5.24B
| $15.9M | 0.01% |
436,276
-10,556
| -2% | -$373K |
|
349
First Interstate BancSystem
FIBK
$3.69B
| $15.6M | 0.01% |
563,224
-287,543
| -34% | -$7.61M |
|
350
DT Midstream
DTM
$14.1B
| $15.5M | 0.01% |
218,794
+118,712
| +119% | +$7.79M |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.